pepmg_

Study summary · research use only

Peptide Epitalon activates chromatin at the old age

Study · human · Neuro endocrinology letters · 2003 · PMID 14647006

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this study of cultured lymphocytes from people aged 76-80 years, the authors examined the synthetic peptide Epitalon's effect on ribosomal gene activity, heterochromatin denaturation parameters, structural C-heterochromatin polymorphism, and facultative heterochromatin variability. They report that Epitalon was associated with activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin, and release of genes described as repressed by age-related chromatin condensation. The authors interpret the findings as showing Epitalon modifying heterochromatin and heterochromatinized chromosome regions in cells of older people.

Abstract

OBJECTIVES and design. We have studied the effect of synthetic peptide Epitalon on the activity of ribosomal genes, denaturation parameters of total heterochromatin, polymorphism of structural C-heterochromatin and the variability of facultative heterochromatin in cultured lymphocytes of persons aged 76-80 years. The obtained data demonstrate that Epitalon induces the activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin and the release of genes repressed due to the age-related condensation of euchromatic chromosome regions. Epitalon has shown its ability to activate chromatin by modifying heterochromatin and heterochromatinized chromosome regions in the cells of older persons.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.